Cargando…
SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article
Coronavirus disease (COVID-19) was first identified in late December 2019. The disease began in Wuhan, Hubei province in China and since then it has spread quickly to many countries all over the world. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814371/ https://www.ncbi.nlm.nih.gov/pubmed/33464546 http://dx.doi.org/10.1007/s13760-020-01577-y |
_version_ | 1783638045762781184 |
---|---|
author | Taher, Tasneem Sheikh, Anum Bilal Anwar, Farah Khosa, Faisal |
author_facet | Taher, Tasneem Sheikh, Anum Bilal Anwar, Farah Khosa, Faisal |
author_sort | Taher, Tasneem |
collection | PubMed |
description | Coronavirus disease (COVID-19) was first identified in late December 2019. The disease began in Wuhan, Hubei province in China and since then it has spread quickly to many countries all over the world. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was majorly seen to overwhelm the respiratory system with mild to severe acute respiratory syndrome considered pathognomic for the disease. However, with time a plethora of symptoms was observed in the patients infected with COVID-19 including strong evidence for neurological symptoms. Evidence suggests that the virus has both central and peripheral nervous system manifestations. Patients, particularly those who suffer from a severe illness, have a central nervous system (CNS) involvement and neurological manifestations. There is precise and targeted documentation of neurological symptoms with details of clinical, neurological, and electrophysiological findings. This review article thus gives an insight into the neuro-invasive potential of COVID-19 and discusses the possible pathogenesis. |
format | Online Article Text |
id | pubmed-7814371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-78143712021-01-18 SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article Taher, Tasneem Sheikh, Anum Bilal Anwar, Farah Khosa, Faisal Acta Neurol Belg Review Article Coronavirus disease (COVID-19) was first identified in late December 2019. The disease began in Wuhan, Hubei province in China and since then it has spread quickly to many countries all over the world. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was majorly seen to overwhelm the respiratory system with mild to severe acute respiratory syndrome considered pathognomic for the disease. However, with time a plethora of symptoms was observed in the patients infected with COVID-19 including strong evidence for neurological symptoms. Evidence suggests that the virus has both central and peripheral nervous system manifestations. Patients, particularly those who suffer from a severe illness, have a central nervous system (CNS) involvement and neurological manifestations. There is precise and targeted documentation of neurological symptoms with details of clinical, neurological, and electrophysiological findings. This review article thus gives an insight into the neuro-invasive potential of COVID-19 and discusses the possible pathogenesis. Springer International Publishing 2021-01-19 2021 /pmc/articles/PMC7814371/ /pubmed/33464546 http://dx.doi.org/10.1007/s13760-020-01577-y Text en © Belgian Neurological Society 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Taher, Tasneem Sheikh, Anum Bilal Anwar, Farah Khosa, Faisal SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article |
title | SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article |
title_full | SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article |
title_fullStr | SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article |
title_full_unstemmed | SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article |
title_short | SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article |
title_sort | sars-cov-2: its potential neurological manifestations and plausible mechanism: a review article |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814371/ https://www.ncbi.nlm.nih.gov/pubmed/33464546 http://dx.doi.org/10.1007/s13760-020-01577-y |
work_keys_str_mv | AT tahertasneem sarscov2itspotentialneurologicalmanifestationsandplausiblemechanismareviewarticle AT sheikhanumbilal sarscov2itspotentialneurologicalmanifestationsandplausiblemechanismareviewarticle AT anwarfarah sarscov2itspotentialneurologicalmanifestationsandplausiblemechanismareviewarticle AT khosafaisal sarscov2itspotentialneurologicalmanifestationsandplausiblemechanismareviewarticle |